338 related articles for article (PubMed ID: 25308528)
1. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R
Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528
[TBL] [Abstract][Full Text] [Related]
2. Treg cells in rheumatoid arthritis: an update.
Cooles FA; Isaacs JD; Anderson AE
Curr Rheumatol Rep; 2013 Sep; 15(9):352. PubMed ID: 23888361
[TBL] [Abstract][Full Text] [Related]
3. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.
Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z
J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998
[TBL] [Abstract][Full Text] [Related]
4. Antigen Specificity Enhances Disease Control by Tregs in Vitiligo.
Mukhatayev Z; Dellacecca ER; Cosgrove C; Shivde R; Jaishankar D; Pontarolo-Maag K; Eby JM; Henning SW; Ostapchuk YO; Cedercreutz K; Issanov A; Mehrotra S; Overbeck A; Junghans RP; Leventhal JR; Le Poole IC
Front Immunol; 2020; 11():581433. PubMed ID: 33335528
[TBL] [Abstract][Full Text] [Related]
5. A quantitative increase in regulatory T cells controls development of vitiligo.
Chatterjee S; Eby JM; Al-Khami AA; Soloshchenko M; Kang HK; Kaur N; Naga OS; Murali A; Nishimura MI; Caroline Le Poole I; Mehrotra S
J Invest Dermatol; 2014 May; 134(5):1285-1294. PubMed ID: 24366614
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
[TBL] [Abstract][Full Text] [Related]
7. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo.
Ben Ahmed M; Zaraa I; Rekik R; Elbeldi-Ferchiou A; Kourda N; Belhadj Hmida N; Abdeladhim M; Karoui O; Ben Osman A; Mokni M; Louzir H
Pigment Cell Melanoma Res; 2012 Jan; 25(1):99-109. PubMed ID: 21985183
[TBL] [Abstract][Full Text] [Related]
8. Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity.
Lin X; Tian H; Xianmin M
Med Hypotheses; 2011 Mar; 76(3):339-42. PubMed ID: 21075543
[TBL] [Abstract][Full Text] [Related]
9. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L
PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532
[TBL] [Abstract][Full Text] [Related]
10. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo.
Le Poole IC; Mehrotra S
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S38-S45. PubMed ID: 28941492
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of immune cell network in autoimmune skin disorders: An update on pemphigus, vitiligo and psoriasis.
Das D; Akhtar S; Kurra S; Gupta S; Sharma A
Cytokine Growth Factor Rev; 2019 Feb; 45():35-44. PubMed ID: 30773437
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo.
Zhen Y; Yao L; Zhong S; Song Y; Cui Y; Li S
Arch Dermatol Res; 2016 Dec; 308(10):703-710. PubMed ID: 27687555
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 reverses depigmentation in Pmel-1 vitiligo mice by increasing the abundance of Tregs in the skin.
Miao X; Xu R; Fan B; Chen J; Li X; Mao W; Hua S; Li B
Sci Rep; 2018 Jan; 8(1):1605. PubMed ID: 29371688
[TBL] [Abstract][Full Text] [Related]
14. scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T
Gellatly KJ; Strassner JP; Essien K; Refat MA; Murphy RL; Coffin-Schmitt A; Pandya AG; Tovar-Garza A; Frisoli ML; Fan X; Ding X; Kim EE; Abbas Z; McDonel P; Garber M; Harris JE
Sci Transl Med; 2021 Sep; 13(610):eabd8995. PubMed ID: 34516831
[TBL] [Abstract][Full Text] [Related]
15. The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics.
Alahgholi-Hajibehzad M; Kasapoglu P; Jafari R; Rezaei N
Expert Rev Clin Immunol; 2015; 11(7):859-70. PubMed ID: 25973691
[TBL] [Abstract][Full Text] [Related]
16. Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo.
Essien KI; Katz EL; Strassner JP; Harris JE
J Invest Dermatol; 2022 Dec; 142(12):3158-3166.e7. PubMed ID: 35777498
[TBL] [Abstract][Full Text] [Related]
17. Initiation and regulation of CD8+T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo.
Steitz J; Wenzel J; Gaffal E; Tüting T
Eur J Cell Biol; 2004 Dec; 83(11-12):797-803. PubMed ID: 15679123
[TBL] [Abstract][Full Text] [Related]
18. Detection of self-reactive CD8⁺ T cells with an anergic phenotype in healthy individuals.
Maeda Y; Nishikawa H; Sugiyama D; Ha D; Hamaguchi M; Saito T; Nishioka M; Wing JB; Adeegbe D; Katayama I; Sakaguchi S
Science; 2014 Dec; 346(6216):1536-40. PubMed ID: 25525252
[TBL] [Abstract][Full Text] [Related]
19. Alteration in regulatory T cells and programmed cell death 1-expressing regulatory T cells in active generalized vitiligo and their clinical correlation.
Tembhre MK; Parihar AS; Sharma VK; Sharma A; Chattopadhyay P; Gupta S
Br J Dermatol; 2015 Apr; 172(4):940-50. PubMed ID: 25376752
[TBL] [Abstract][Full Text] [Related]
20. Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance.
Chen J; Wang X; Cui T; Ni Q; Zhang Q; Zou D; He K; Wu W; Ma J; Wang Y; Guo W; Li C; Li S
J Autoimmun; 2022 Jul; 131():102859. PubMed ID: 35792518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
